Bleakley Financial Group’s VistaGen Therapeutics VTGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-502
Closed -$1.88K 988
2023
Q1
$1.88K Buy
502
+17
+4% +$64 ﹤0.01% 910
2022
Q4
$1.5K Buy
+485
New +$1.5K ﹤0.01% 877